COVID-19: Staging of a New Disease

Carlos Cordon-Cardo; Elisabet Pujadas; Ania Wajnberg; Robert Sebra; Gopi Patel; Adolfo Firpo-Betancourt; Mary Fowkes; Emilia Sordillo; Alberto Paniz-Mondolfi; Jill Gregory; Florian Krammer; Viviana Simon; Luis Isola; Patrick Soon-Shiong; Judith A. Aberg; Valentin Fuster; David L. Reich

doi:10.1016/j.ccell.2020.10.006

COVID-19: Staging of a New Disease

Carlos Cordon-Cardo, Elisabet Pujadas, Ania Wajnberg, Robert Sebra, Gopi Patel, Adolfo Firpo-Betancourt, Mary Fowkes, Emilia Sordillo, Alberto Paniz-Mondolfi, Jill Gregory, Florian Krammer, Viviana Simon, Luis Isola, Patrick Soon-Shiong, Judith A. Aberg, Valentin Fuster, David L. Reich

Research output: Contribution to journal › Comment/debate

43 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.

Original language	English
Pages (from-to)	594-597
Number of pages	4
Journal	Cancer Cell
Volume	38
Issue number	5
DOIs	https://doi.org/10.1016/j.ccell.2020.10.006
State	Published - 9 Nov 2020

Access to Document

10.1016/j.ccell.2020.10.006

Cite this

@article{54ae4e8719624edaa4c13f7545c82f40,

title = "COVID-19: Staging of a New Disease",

abstract = "Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.",

author = "Carlos Cordon-Cardo and Elisabet Pujadas and Ania Wajnberg and Robert Sebra and Gopi Patel and Adolfo Firpo-Betancourt and Mary Fowkes and Emilia Sordillo and Alberto Paniz-Mondolfi and Jill Gregory and Florian Krammer and Viviana Simon and Luis Isola and Patrick Soon-Shiong and Aberg, {Judith A.} and Valentin Fuster and Reich, {David L.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = nov,

day = "9",

doi = "10.1016/j.ccell.2020.10.006",

language = "English",

volume = "38",

pages = "594--597",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - COVID-19

T2 - Staging of a New Disease

AU - Cordon-Cardo, Carlos

AU - Pujadas, Elisabet

AU - Wajnberg, Ania

AU - Sebra, Robert

AU - Patel, Gopi

AU - Firpo-Betancourt, Adolfo

AU - Fowkes, Mary

AU - Sordillo, Emilia

AU - Paniz-Mondolfi, Alberto

AU - Gregory, Jill

AU - Krammer, Florian

AU - Simon, Viviana

AU - Isola, Luis

AU - Soon-Shiong, Patrick

AU - Aberg, Judith A.

AU - Fuster, Valentin

AU - Reich, David L.

PY - 2020/11/9

Y1 - 2020/11/9

N2 - Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.

AB - Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.

UR - http://www.scopus.com/inward/record.url?scp=85093943936&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2020.10.006

DO - 10.1016/j.ccell.2020.10.006

M3 - Comment/debate

C2 - 33086031

AN - SCOPUS:85093943936

SN - 1535-6108

VL - 38

SP - 594

EP - 597

JO - Cancer Cell

JF - Cancer Cell

IS - 5

ER -

COVID-19: Staging of a New Disease

Abstract

Access to Document

Fingerprint

Cite this